Cargando…
Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
SIMPLE SUMMARY: Identification of human papillomavirus (HPV) genotypes beyond HPV16 and HPV18 by extended genotyping (XGT) for cervical cancer screening, allows for risk stratification for clinical management. We estimated the resource use, cost, and quality-adjusted life years (QALY) comparing XGT...
Autores principales: | Chua, Brandon, Lim, Li Min, Ng, Joseph Soon Yau, Ma, Yan, Wee, Hwee Lin, Caro, J. Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046888/ https://www.ncbi.nlm.nih.gov/pubmed/36980698 http://dx.doi.org/10.3390/cancers15061812 |
Ejemplares similares
-
Correction: Chua et al. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. Cancers 2023, 15, 1812
por: Chua, Brandon, et al.
Publicado: (2023) -
Health care provider's experience and perspective of cervical cancer screening in Singapore: A qualitative study
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022) -
Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022) -
Singapore
por: Wee Loon, Ng-Loy
Publicado: (2008) -
Barriers to and Facilitators of Cervical Cancer Screening among Women in Southeast Asia: A Systematic Review
por: Chua, Brandon, et al.
Publicado: (2021)